Showing results (191-200 of 330) with videos related to
Sort By:
Pageof 33
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|December 13, 2019
[Ablative treatment options for locally advanced unresectable and borderline resectable pancreatic carcinoma]Yusef Moulla, Tim-Ole Petersen, Bettina Maiwald, et al.Zeitschrift Fur Psychosomatische Medizin Und Psychotherapie|September 10, 2003
[Interdisciplinary psychoeducational intervention by oncologists proved helpful for cancer patients]Harald Gündel, Florian Lordick, Tobias Brandl, et al.Radiology|April 28, 2007
Rectal cancer: MR imaging before neoadjuvant chemotherapy and radiation therapy for prediction of tumor-free circumferential resection margins and long-term survivalHinrich A Wieder, Robert Rosenberg, Florian Lordick, et al.Zeitschrift Fur Gastroenterologie|April 21, 2017
An unusual hypoechoic solid mass in the pancreatic headValentin Blank, Katrin Schierle, Ulrich Hacker, et al.Expert Review of Anticancer Therapy|March 24, 2020
Management of early-stage gastro-esophageal cancers: expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international facultyAmitesh C Roy, Jeremy Shapiro, Matt Burge, et al.Onkologie|March 2, 2011
Immunotherapy of peritoneal carcinomatosis with the antibody catumaxomab in colon, gastric, or pancreatic cancer: an open-label, multicenter, phase I/II trialMichael A Ströhlein, Florian Lordick, Dominik Rüttinger, et al.Cell Death Discovery|September 26, 2021
Human tissue cultures of lung cancer predict patient susceptibility to immune-checkpoint inhibitionDavid Junk, Sebastian Krämer, Johannes Broschewitz, et al.International Journal of Colorectal Disease|December 4, 2008
The predictive value of metabolic response to preoperative radiochemotherapy in locally advanced rectal cancer measured by PET/CTRobert Rosenberg, Ken Herrmann, Ralf Gertler, et al.BMC Cancer|June 28, 2011
Sequential FDG-PET and induction chemotherapy in locally advanced adenocarcinoma of the Oesophago-gastric junction (AEG): the Heidelberg Imaging program in Cancer of the oesophago-gastric junction during Neoadjuvant treatment: HICON trialSylvie Lorenzen, Carl von Gall, Annika Stange, et al.Oncology Research and Treatment|May 11, 2016
Symptoms and Needs of Head and Neck Cancer Patients at Diagnosis of Incurability - Prevalences, Clinical Implications, and Feasibility of a Prospective Longitudinal Multicenter Cohort StudyBernd Alt-Epping, Wiebke Seidel, Jeannette Vogt, et al.Pageof 33